Finally, we conducted a retrospective analysis on early breast cancer patients which revealed that USP19 expression levels correlated with poor outcome and reduced distant metastasis free survival, hence serving as a prognostic factor in early breast cancer patients. This evidence concerns the gene USP19 and breast carcinoma.